Product Information

METOPROLOL SUCC ER 100 MG TAB is a generic product labeled by Major Pharmaceuticals, priced at $0.0850 per EA under NDC 00904632461. Its NADAC has been published 649 times since Apr 30, 2014.

FDA first approved this application on Aug 15, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Metoprolol succinate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

METOPROLOL SUCC ER 100 MG TAB

Metoprolol succinate
$0.0850per EA
Low Outlier

Strength

100 mg/1

NDC

00904632461

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

9/23/2026

Active Ingredients

METOPROLOL SUCCINATE

Approval Type

Generic (ANDA)

FDA Application

ANDA078889

FDA Approved

8/15/2012

TE Code

AB

On Market Since

9/10/2012

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price Statistics

The NADAC for METOPROLOL SUCC ER 100 MG TAB has been published 649 times since Apr 30, 2014, and over the history we have for it it has declined 86.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0850 per EA
All-time high$0.6428 (May 14, 2014)
All-time low$0.0813 (Apr 22, 2026)
52-week high$0.0966
52-week low$0.0813
Median price$0.2056
Average price$0.2719
Largest weekly change+47.2% (Mar 20, 2024)
Weeks tracked649
Tracking sinceApr 30, 2014

Price History

1W

0.0%

1M

-7.1%

3M

-6.2%

6M

+3.9%

1Y

-8.1%

3Y

-34.5%

5Y

-44.2%

All

-86.8%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METOPROLOL SUCC ER 100 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL SUCC ER 100 MG TAB, manufactured by Major Pharmaceuticals, is $0.0850 per EA (NDC 00904632461), effective Sep 30, 2026.

How has the price of METOPROLOL SUCC ER 100 MG TAB changed over time?

Over the history we have for it, the NADAC for METOPROLOL SUCC ER 100 MG TAB has declined 86.8%. It has been tracked across 649 weekly CMS publications since Apr 30, 2014.

What are the highest and lowest recorded NADAC prices for METOPROLOL SUCC ER 100 MG TAB?

Since Apr 30, 2014, the NADAC for METOPROLOL SUCC ER 100 MG TAB has ranged from a low of $0.0813 (Apr 22, 2026) to a high of $0.6428 (May 14, 2014), with a median of $0.2056 per EA.

Are there cheaper alternatives to METOPROLOL SUCC ER 100 MG TAB?

9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METOPROLOL SUCC ER 100 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures METOPROLOL SUCC ER 100 MG TAB?

METOPROLOL SUCC ER 100 MG TAB (NDC 00904632461) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.